These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29297424)

  • 21. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
    Loveday M; Wallengren K; Reddy T; Besada D; Brust JCM; Voce A; Desai H; Ngozo J; Radebe Z; Master I; Padayatchi N; Daviaud E
    PLoS One; 2018; 13(4):e0196003. PubMed ID: 29668748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.
    Ebonwu JI; Tint KS; Ihekweazu C
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1043-8. PubMed ID: 23827028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Loveday M; Wallengren K; Brust J; Roberts J; Voce A; Margot B; Ngozo J; Master I; Cassell G; Padayatchi N
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):163-71. PubMed ID: 25574914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Moore BK; Anyalechi E; van der Walt M; Smith S; Erasmus L; Lancaster J; Morris S; Ndjeka N; Ershova J; Ismail N; Burton D; Menzies H
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):663-9. PubMed ID: 25946356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
    Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E
    Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N
    PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.
    Smith CM; Lessells R; Grant AD; Herbst K; Tanser F
    Int J Tuberc Lung Dis; 2018 Mar; 22(3):287-293. PubMed ID: 29471906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes.
    Loveday M; Padayatchi N; Wallengren K; Roberts J; Brust JC; Ngozo J; Master I; Voce A
    PLoS One; 2014; 9(4):e94016. PubMed ID: 24718306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
    Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L
    Glob Health Action; 2015; 8():25964. PubMed ID: 25623609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in children.
    Schaaf HS; Garcia-Prats AJ; du Preez K; Rautenbach C; Hesseling AC
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1249-56. PubMed ID: 27510254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Jensenius M; Winje BA; Blomberg B; Mengshoel AT; Lippe Bv; Hannula R; Bruun JN; Knudsen PK; Rønning JO; Heldal E; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):786-92. PubMed ID: 27155182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yield of systematic household contact investigation for tuberculosis in a high-burden metropolitan district of South Africa.
    Kigozi NG; Heunis JC; Engelbrecht MC
    BMC Public Health; 2019 Jul; 19(1):867. PubMed ID: 31269950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    Loveday M; Hlangu S; Furin J
    PLoS One; 2020; 15(12):e0242604. PubMed ID: 33347448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
    Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
    Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.